| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 1.892 | 4.082 | 6.269 | 12.410 | 12.012 | 23.605 | 26.043 | 27.323 | 35.249 |
| Total Income - EUR | - | 1.892 | 4.082 | 6.269 | 12.410 | 12.012 | 23.605 | 26.043 | 27.323 | 35.249 |
| Total Expenses - EUR | - | 271 | 361 | 508 | 725 | 1.125 | 1.495 | 1.252 | 1.100 | 1.132 |
| Gross Profit/Loss - EUR | - | 1.620 | 3.721 | 5.761 | 11.685 | 10.888 | 22.110 | 24.791 | 26.223 | 34.117 |
| Net Profit/Loss - EUR | - | 1.564 | 3.598 | 5.573 | 11.313 | 10.552 | 21.416 | 24.025 | 22.111 | 28.767 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Respir Cris Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 523 | 198 | 0 | 0 | 0 |
| Current Assets | - | 1.844 | 4.015 | 6.269 | 11.714 | 10.584 | 21.897 | 24.438 | 23.279 | 30.676 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 61 | 0 | 537 | 989 | 873 | 2.582 | 1.523 | 1.742 | 0 |
| Cash | - | 1.783 | 4.015 | 5.732 | 10.725 | 9.711 | 19.315 | 22.915 | 21.537 | 30.676 |
| Shareholders Funds | - | 1.608 | 3.651 | 5.625 | 11.363 | 10.601 | 21.465 | 24.074 | 22.160 | 28.815 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 236 | 365 | 644 | 351 | 505 | 631 | 364 | 1.120 | 1.861 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Respir Cris Med Srl